Pantoprazole

Pantoprazole belongs to the family of proton pump inhibitors, the PPIs. It blocks the enzyme H+/K+ ATPase, the proton pump located in the parietal cells of the stomach wall. This pump is the final step that releases acid into the stomach, and by neutralising it, pantoprazole strongly reduces gastric acid secretion. The molecule is a prodrug: it stays inactive until the acidity of the secretory canaliculi of the parietal cells cleaves and activates it, precisely where it needs to act.

Once activated, pantoprazole binds irreversibly to the pump. Acid secretion therefore stays suppressed for 24 to 48 hours, the time the cell needs to build new pumps, even though the molecule leaves the blood quickly: its plasma half-life is about one hour and its concentration declines in a biexponential way. The liver clears it, mainly through the enzyme CYP2C19 and, more marginally, through CYP3A4. This dual feature, a lasting action on the pump and a brief passage through the blood, explains why a single dose per day is enough.

Pantoprazole is prescribed when stomach acid causes damage or symptoms. It treats gastro-oesophageal reflux, where acid rises towards the oesophagus, as well as erosive oesophagitis, the resulting inflammation of the oesophageal wall. It also treats ulcer disease, that is, ulcers of the stomach and the duodenum. In these situations, acid keeps the pain going and prevents the tissues from healing.

It is also indicated in states of acid hypersecretion, such as Zollinger-Ellison syndrome, where a tumour drives the stomach to produce far too much acid. The principle stays the same from one indication to the next: by lowering acidity, pantoprazole lets the mucosa repair itself and calms symptoms such as heartburn. The choice of dose and duration depends on the cause, from passing reflux to a disease that requires long treatment.

Pantoprazole is usually taken once a day, in the morning, preferably about one hour before a meal. The tablet is swallowed whole with a glass of water, without chewing or crushing it. Proton pumps switch on at mealtimes, and the PPI works better when it is already in place when they start up.

Regularity matters as much as timing, because the effect relies on inhibition sustained day after day. It is better not to stop treatment on your own: after prolonged use, stopping can trigger a rebound, with acidity rising above its level before treatment. Any change to the dose or duration is decided with the doctor who set the indication.

In clinical trials conducted in adults, the most frequent adverse effects were headaches, in 12.2% of people, diarrhoea in 8.8% and nausea in 7.0%. Then came abdominal pain in 6.2%, vomiting in 4.3%, flatulence in 3.9%, dizziness in 3.0% and joint pain in 2.8%. The NHS places several of these effects, headaches, diarrhoea, nausea, constipation, dry mouth or fatigue, at fewer than one person in a hundred in everyday use.

Serious effects remain rare, at fewer than one person in a thousand: liver damage, kidney damage, severe and persistent diarrhoea suggesting intestinal inflammation, or joint pain accompanied by a rash on areas exposed to the sun. By reducing the stomach’s acid barrier, PPIs also increase the risk of digestive infections, including Clostridium difficile infection and other food-borne infections. These signs call for prompt medical advice rather than stopping on your own.

Prolonged treatment shifts two nutrients in particular. After three months or more, the level of magnesium in the blood may fall, to the point of causing fatigue, confusion, dizziness, muscle contractions and irregular heart rhythm; this fall is sometimes hard to correct while the PPI is continued, and severe hypomagnesaemia exposes a person to tetany, seizures and rhythm disorders. Magnesium is found in pumpkin seeds, almonds, dark chocolate, spinach, legumes and wholegrain cereals. The plate keeps the stores up meal after meal, without replacing a blood test when one becomes necessary.

The second nutrient is vitamin B12. By lowering the acidity that helps release it from food, a PPI taken for a year or more can lead to a deficiency, whose signs are intense fatigue, a red and sore tongue, mouth ulcers and tingling; the phenomenon remains clinically rare. Vitamin B12 comes almost solely from animal products: fish such as sardines, eggs, meat and dairy products. When absorption is slowed by the treatment, food alone does not always close the gap, and this is where a targeted intake makes sense, in addition to your treatment and never in its place.

Stomach acidity takes part in the absorption of certain medicines, so pantoprazole can change their effect. By lowering this acidity, a PPI reduces, for example, the absorption of an antifungal such as ketoconazole. The NHS for its part reports reduced absorption of antifungals such as itraconazole, posaconazole and voriconazole, as well as interactions with methotrexate, warfarin, rifampicin and HIV medicines; St John’s wort, for its part, reduces its effectiveness. Since pantoprazole passes through the enzyme CYP2C19, the list of medicines and plants to report to the doctor or pharmacist deserves to be kept up to date.

Monitoring targets magnesium above all in people at risk, notably kidney transplant patients, in whom a blood test is recommended. Over time, the use of pantoprazole is associated with an increased risk of bone fractures and vitamin B12 deficiency, which monitoring seeks to spot before they appear. Finally, stopping after a long period is prepared with the doctor, because acid secretion can rebound above its initial level.